Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 131

1.

Forever-Fit Summer Camp: The Impact of a 6-Week Summer Healthy Lifestyle Day Camp on Anthropometric, Cardiovascular, and Physical Fitness Measures in Youth With Obesity.

El Mikati HK, Boateng AO, McKinney BM, Haberlin-Pittz K, Pike J, Perry P, Hannon TS, Yazel-Smith L.

J Prim Care Community Health. 2020 Jan-Dec;11:2150132720903888. doi: 10.1177/2150132720903888.

2.

In utero Exposure to Anesthetics Alters Neuronal Migration Pattern in Developing Cerebral Cortex and Causes Postnatal Behavioral Deficits in Rats.

Gluncic V, Moric M, Chu Y, Hanko V, Li J, Lukić IK, Lukić A, Edassery SL, Kroin JS, Persons AL, Perry P, Kelly L, Shiveley TJ, Nice K, Napier CT, Kordower JH, Tuman KJ.

Cereb Cortex. 2019 Dec 17;29(12):5285-5301. doi: 10.1093/cercor/bhz065.

PMID:
31220224
3.

Correction: Loss of the BMP Antagonist, SMOC-1, Causes Ophthalmo-Acromelic (Waardenburg Anophthalmia) Syndrome in Humans and Mice.

Rainger J, van Beusekom E, Ramsay JK, McKie L, Al-Gazali L, Pallotta R, Saponari A, Branney P, Fisher M, Morrison H, Bicknell L, Gautier P, Perry P, Sokhi K, Sexton D, Bardakjian TM, Schneider AS, Elcioglu N, Ozkinay F, Koenig R, Mégarbané A, Semerci CN, Khan A, Zafar S, Hennekam R, Sousa SB, Ramos L, Garavelli L, Furga AS, Wischmeijer A, Jackson IJ, Gillessen-Kaesbach G, Brunner HG, Wieczorek D, van Bokhoven H, FitzPatrick DR.

PLoS Genet. 2018 Dec 26;14(12):e1007866. doi: 10.1371/journal.pgen.1007866. eCollection 2018 Dec.

4.

A cross-species approach to disorders affecting brain and behaviour.

Devinsky O, Boesch JM, Cerda-Gonzalez S, Coffey B, Davis K, Friedman D, Hainline B, Houpt K, Lieberman D, Perry P, Prüss H, Samuels MA, Small GW, Volk H, Summerfield A, Vite C, Wisniewski T, Natterson-Horowitz B.

Nat Rev Neurol. 2018 Nov;14(11):677-686. doi: 10.1038/s41582-018-0074-z. Review.

5.

DISC1 regulates N-methyl-D-aspartate receptor dynamics: abnormalities induced by a Disc1 mutation modelling a translocation linked to major mental illness.

Malavasi ELV, Economides KD, Grünewald E, Makedonopoulou P, Gautier P, Mackie S, Murphy LC, Murdoch H, Crummie D, Ogawa F, McCartney DL, O'Sullivan ST, Burr K, Torrance HS, Phillips J, Bonneau M, Anderson SM, Perry P, Pearson M, Constantinides C, Davidson-Smith H, Kabiri M, Duff B, Johnstone M, Polites HG, Lawrie SM, Blackwood DH, Semple CA, Evans KL, Didier M, Chandran S, McIntosh AM, Price DJ, Houslay MD, Porteous DJ, Millar JK.

Transl Psychiatry. 2018 Sep 6;8(1):184. doi: 10.1038/s41398-018-0228-1.

6.

Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder.

Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, McQuade RD, Nyilas M, Carson WH.

J Affect Disord. 2018 Feb;227:649-656. doi: 10.1016/j.jad.2017.10.035. Epub 2017 Oct 24.

PMID:
29174738
7.

Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores.

Ismail Z, Peters-Strickland T, Miguelez M, Baker RA, Hertel P, Eramo A, Jin N, Perry P, Sanchez R, McQuade RD, Kane JM.

J Clin Psychopharmacol. 2017 Jun;37(3):347-350. doi: 10.1097/JCP.0000000000000710.

8.

Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study.

Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry P, Hertel P, Such P, Salzman PM, McQuade RD, Nyilas M, Carson WH.

J Clin Psychiatry. 2017 Mar;78(3):324-331. doi: 10.4088/JCP.16m11201.

9.

Novel application of a percutaneous left ventricular assist device as a bridge to transplant in a paediatric patient with severe heart failure due to viral myocarditis.

Perry P, David E, Atkins B, Raff G.

Interact Cardiovasc Thorac Surg. 2017 Mar 1;24(3):474-476. doi: 10.1093/icvts/ivw387.

PMID:
28040759
10.
11.

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study.

Davis LL, Ota A, Perry P, Tsuneyoshi K, Weiller E, Baker RA.

Brain Behav. 2016 Jul 24;6(10):e00520. eCollection 2016 Oct.

12.

The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study.

Malla A, Ota A, Nagamizu K, Perry P, Weiller E, Baker RA.

Int Clin Psychopharmacol. 2016 Nov;31(6):307-14. doi: 10.1097/YIC.0000000000000140.

13.

Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment.

Weisler RH, Ota A, Tsuneyoshi K, Perry P, Weiller E, Baker RA, Sheehan DV.

J Affect Disord. 2016 Nov 1;204:40-7. doi: 10.1016/j.jad.2016.06.001. Epub 2016 Jun 4.

14.

The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study.

Citrome L, Ota A, Nagamizu K, Perry P, Weiller E, Baker RA.

Int Clin Psychopharmacol. 2016 Jul;31(4):192-201. doi: 10.1097/YIC.0000000000000123.

PMID:
26963842
15.

Fixation of the Proximal Metatarsal Crescentic Osteotomy Using a Head Locking X-Plate.

Pauli W, Koch A, Testa E, Dopke K, Perry P, Honigmann P.

Foot Ankle Int. 2016 Feb;37(2):218-26. doi: 10.1177/1071100715606892. Epub 2015 Sep 30.

PMID:
26424725
16.

Lanosterol reverses protein aggregation in cataracts.

Zhao L, Chen XJ, Zhu J, Xi YB, Yang X, Hu LD, Ouyang H, Patel SH, Jin X, Lin D, Wu F, Flagg K, Cai H, Li G, Cao G, Lin Y, Chen D, Wen C, Chung C, Wang Y, Qiu A, Yeh E, Wang W, Hu X, Grob S, Abagyan R, Su Z, Tjondro HC, Zhao XJ, Luo H, Hou R, Jefferson J, Perry P, Gao W, Kozak I, Granet D, Li Y, Sun X, Wang J, Zhang L, Liu Y, Yan YB, Zhang K.

Nature. 2015 Jul 30;523(7562):607-11. doi: 10.1038/nature14650. Epub 2015 Jul 22. Erratum in: Nature. 2015 Oct 22;526(7574):595.

PMID:
26200341
17.

Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice.

Berry RL, Ozdemir DD, Aronow B, Lindström NO, Dudnakova T, Thornburn A, Perry P, Baldock R, Armit C, Joshi A, Jeanpierre C, Shan J, Vainio S, Baily J, Brownstein D, Davies J, Hastie ND, Hohenstein P.

Dis Model Mech. 2015 Aug 1;8(8):903-17. doi: 10.1242/dmm.018523. Epub 2015 May 14.

18.

Is lithium a neuroprotective agent?

Vo TM, Perry P, Ellerby M, Bohnert K.

Ann Clin Psychiatry. 2015 Feb;27(1):49-54. Review.

PMID:
25696782
19.

Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study.

Peters-Strickland T, Baker RA, McQuade RD, Jin N, Eramo A, Perry P, Johnson BR, Duca A, Sanchez R.

NPJ Schizophr. 2015 Nov 4;1:15039. doi: 10.1038/npjschz.2015.39. eCollection 2015.

20.

Greener clinics, better care.

Perry P.

Virtual Mentor. 2014 Sep 1;16(9):726-31. doi: 10.1001/virtualmentor.2014.16.09.stas1-1409. No abstract available.

Supplemental Content

Loading ...
Support Center